No Detail Found!

Diagnostic value of CT liver-to-spleen attenuation ratio in patients with non-alcoholic fatty liver disease and atherosclerotic plaque

Author(s)
Dong Han Department of Medical Imaging, Beijing Changping Hospital of Chinese Medicine, ,Beijing 102200,P.R. China
Chongan He Department of Medical Imaging, Beijing Changping Hospital of Chinese Medicine, ,Beijing 102200,P.R. China
Shuang Gu Department of Medical Imaging, Beijing Changping Hospital of Chinese Medicine, ,Beijing 102200,P.R. China
Dongxuan Zhang Department of Spleen and Stomach Diseases, Beijing Changping Hospital of Chinese Medicine, ,Beijing 102200,P.R. China
Liyun Xu Department of Ultrasound, Beijing Changping Hospital of Chinese Medicine, South Section of Donghuan Road,Beijing 102200,P.R. China
Abstract
Objective: To explore the clinical value of computed tomography (CT) liver-to-spleen (L/S) attenuation ratio in patients with non-alcoholic fatty liver disease (NAFLD) accompanied by atherosclerotic plaque (AP). Methods: This was a single-center, retrospective, observational study of patients who were diagnosed with NAFLD undergoing CT scans at Beijing Changping Hospital of Chinese Medicine from April 2020 to April 2022. Patients were grouped according to whether they had a diagnosis of AP or not. Healthy individuals without NAFLD undergoing CT scans during the same period were also included as a control group. The patients were matched for gender, age, and BMI in a 1:1:1 ratio. Correlations between the CT L/S attenuation ratio, liver function indicators, and blood lipid levels were assessed in the three groups. The predictive value of the CT L/S attenuation ratio was evaluated using the receiver operating characteristic (ROC) curve and the area under the curve (AUC) analyses. Results: Eighty-nine cases in each group. The three groups had significant diferences in liver function and blood lipid levels (P0.05), but it positively correlated with high-density lipoprotein (HDL) and negatively correlated with low-density lipoprotein (LDL), triglycerides (TG), and total cholesterol (TC) (P<0.05). The CT L/S attenuation ratio had a high predictive value for NAFLD patients with AP (AUC=0.859). Conclusions: The CT L/S attenuation ratio in NAFLD patients with AP is significantly reduced and is closely related to the levels of blood lipid indicators. The CT L/S attenuation ratio has a high predictive value for NAFLD patients with AP.
Publication Details
Page(s) 2416-2421
Published Journal: Pakistan Journal of Medical Sciences, Volume: 40, Issue: 10, Year: 2024

Request the full text from PASTIC

Keywords
Non-Alcoholic Fatty Liver Disease, Atherosclerotic plaque, CT Liver-to-spleen attenuation ratio
References
Stols-Gonçalves D,Hovingh GK,Nieuwdorp M,Holleboom AG .2019 .NAFLD and Atherosclerosis: Two Sides of the Same Dysmetabolic Coin? Trends Endocrinol Metab TEM. , 08(12) : 891-902.
Altaf B,Rehman A,Jawed S,Raouf A .2020 .Association of liver biomarkers and cytokeratin-18 in Nonalcoholic fatty liver disease patients. Pak J Med Sci, 10(3) : 1674-390.
Lonardo A,Nascimbeni F,Mantovani A,Targher G .2017 .. atherosclerosis and NASH: Cause or consequence? J Hepatol, 09(2) : 335-352.
Targher G,Bertolini L,Padovani R,Rodella S,Tessari R,Zenari L .2007 .Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients. Diabetes Care, 10(5) : 2247-1218.
Teng ML,Ng CH,Huang DQ,Chan KE,Tan DJ,Lim WH .2022 .Global incidence and prevalence of nonalcoholic fatty liver disease. Clin Mol Hepatol, 0365(Suppl) : S32-S42.
LB VanWagner .2018 .New insights into NAFLD and subclinical coronary atherosclerosis. J Hepatol, 01(5) : 890-892.
Abdallah LR,De Matos RC,Souza E,Vieira-Soares YPDM,MullerMachado D,Pollo-Flores G,P G .2020 .Non-alcoholic Fatty Liver Disease and Its Links with Inflammation and Atherosclerosis. Curr Atheroscler Rep, 10(1) : .
Cazac GD,Lăcătu-u CM,Mihai C,Grigorescu ED,Onofriescu A,Mihai BM .2022 .New Insights into Non-Alcoholic Fatty Liver Disease and Coronary Artery Disease: The Liver-Heart Axis. , 10(8) : 1189.
Nishihara T,Miyoshi T,Ichikawa K,Osawa K,Nakashima M,Miki T .2022 .Association of Oxidized Low-Density Lipoprotein in Nonalcoholic Fatty Liver Disease with High-Risk Plaque on Coronary Computed Tomography Angiography: A Matched Case-Control Study. J Clin Med, 10(10) : 2838.
Starekova J,Hernando D,Pickhardt PJ,Reeder SB .2021 .Quantification of Liver Fat Content with CT and MRI: State of the Art. Radiology, 10(2) : 250-262.
Wells MM,Li Z,Addeman B,McKenzie CA,Mujoomdar A,Beaton M,Hepatol J Gastroenterol .2016 .Computed Tomography Measurement of Hepatic Steatosis: Prevalence of Hepatic Steatosis in a Canadian Population. , 10 : .
Dendl LM,Schreyer AG .2012 .. Herausforderung? Radiol, 10(8) : 745-752.
Lawrence DA,Oliva IB,Israel GM .2012 .Detection of hepatic steatosis on contrast-enhanced CT images: diagnostic accuracy of identification of areas of presumed focal fatty sparing. Am J Roentgenol, 10(1) : 44-47.
Poyraz N,Ozer H,Baloglu I,Kadıyoran C,Yılmaz PD,Sertdemir AL .2022 .Liver-Spleen Ratio: Can It Be Used for the Prediction of Coronary Artery Disease?. Anatol J Cardiol, 10(10) : 762-770.
Tokushige K,Ikejima K,Ono M,Eguchi Y,Kamada Y,Itoh Y,Gastroenterol J .2021 .Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 2020. , 10(11) : 951-963.
Finney AC,Das S,Kumar D,McKinney MP,Cai B,Yurdagul A .2023 .The interplay between nonalcoholic fatty liver disease and atherosclerotic cardiovascular disease. Front Cardiovasc Med, 10 : 1116861.
Shi W,Li G,Cui Z,Zhang D,Wang W,Zhao X .2021 .Study on the Relationship between Liver/Spleen CT Value Ratio and NonAlcoholic Fatty Liver with Atherosclerotic Plaque. J Clin Radiol, 02(2) : 227-281.
Yang Q,Wang Z,Huang Z,Zhang S,Xie Y,Wang X .2022 .Evaluation of Aortic Distensibility in Patients with Nonalcoholic Fatty Liver Using CT. Curr Med Imaging, 10(8) : 883-887.
Hideo-Kajita A,Garcia-Garcia HM,Wopperer SB,Freire AFD,Ozaki Y,Cavalcante R .2020 .Correlation between computed tomography adapted leaman score and computed tomography liver and spleen attenuation parameters for non-alcoholic fatty liver disease as well as respective inflammatory mediators. Int J Cardiovasc Imaging, 10(12) : 2383-2391.
Zhao J,Fan H,Wang T,Yu B,Mao S,Wang X .2022 .TyG index is positively associated with risk of CHD and coronary atherosclerosis severity among NAFLD patients. Cardiovasc Diabetol, 10(1) : 123.
Li H,Yu XH,Ou X,Ouyang XP,Tang CK .2021 .Hepatic cholesterol transport and its role in non-alcoholic fatty liver disease and atherosclerosis. Prog Lipid Res, 10 : 101109.
Wójcik-Cichy K,Koślińska-Berkan E,Piekarska A .2018 .The influence of NAFLD on the risk of atherosclerosis and cardiovascular diseases. Clin Exp Hepatol, 10(1) : 1-6.
Heeren J,Scheja L .2021 .Metabolic-associated fatty liver disease and lipoprotein metabolism. Mol Metab, 10 : 101238.
Tanase DM,Gosav EM,Petrov D,Jucan AE,Lacatusu CM,Floria M .2053 .Involvement of Ceramides in Non-Alcoholic Fatty Liver Disease (NAFLD) Atherosclerosis (ATS) Development: Mechanisms and Therapeutic Targets. , 10(11) : .
Peters KM,Wilson RB,Borradaile NM .2018 .Non-parenchymal hepatic cell lipotoxicity and the coordinated progression of non-alcoholic fatty liver disease and atherosclerosis. Curr Opin Lipidol, 10(5) : 417-422.
0

Citations

0

Downloads

87

Views